Indiana University announced a partnership with the Indianapolis-based IU Health hospital system that will launch four primary care clinics in Bloomington, which can be visited for no extra charge by those enrolled in IU’s health plans.
Paul M. Pittman, one of four principals in a troubled Indianapolis-based condo developer, filed personal bankruptcy this week.
The new Indianapolis-based organization was formed by Nursing 2000, Nursing 2000 North and the Indiana Nursing Workforce Development Coalition, all of which focused on generating an adequate supply of well-trained nurses.
The “Get on Board” event will include exhibits from 68 local not-for-profit groups looking to fill board vacancies. The Lacy Leadership Association expects more than 500 people to attend.
Eastman Kodak Co. reportedly looked at relocating a 500-person research-and-development center to Indiana, but will instead stay put in Ohio, according to a company official.
Aecom, a global firm that also is one of the companies rebuilding the World Trade Center site in New York City, designed the Deep Rock Tunnel Connector, the linchpin of a tunnel system the city will build to handle sewage overflows during rain storms.
Of every 100 Hoosiers who enter two- or four-year public colleges in Indiana, only 39 graduate, even when given four years to complete a two-year degree and eight years to complete a four-year degree.
Indianapolis’ largest independent physician group, American Health Network, doesn’t want to sell to a hospital, but its CEO hopes it can hold on until accountable care kicks in.
Dr. Ed Kowlowitz, owner and medical director of the Center for Pain Management in Indianapolis, recently challenged a regional Medicare reimbursement policy and, surprisingly, won. He spoke with IBJ about the experience, as well how his three-physician practice is growing even while many physician practices are selling to hospitals.
Even though Google Inc. has given up on the business of electronic personal health records, Fort Wayne-based NoMoreClipboard.com is launching a new service it thinks will crack open the market.
If approved for continuation maintenance, Eli Lilly and Co.’s Alimta could be used for longer stretches in lung cancer patients, generating more revenue.
Former policyholders of WellPoint Inc., who won a right to a class-action trial over their claims that they were shortchanged when the company went public a decade ago, will have to put their trial plans on hold.
At three community health centers, all patients will be asked about their alcohol and drug usage confidentially, as part of an early-intervention approach designed to cut down addictions and reduce hospitalization.
Residents of the Anderson area—when they paid with health insurance provided by an employer—spent 76 percent more on health care in 2009 than the average American with employer health insurance, highest among all metropolitan areas in the nation.
The hype over accountable care organizations—something every major hospital in Indianapolis is moving to become—is increasingly being laced with skepticism as the economics behind the idea get more scrutiny.
Indianapolis-based SynCare LLC has been touting its growth in Missouri since it entered the market in 2009. But now SynCare’s excursions in the show-me state have turned into a nightmare.
The decision last year by the U.S. Department of Health and Human Services not to exclude health insurance brokers commissions from a provision in the 2010 health reform law has been “devastating to brokers,” broker advocate Janet Trautwein said during an August speech in Fishers, and there are signs that Congress will act to reverse the policy.
The next four years could be rough for makers of medical devices and orthopedic implants, including Bloomington-based Cook Medical Inc. and Warsaw-based Zimmer Holding Inc. and Biomet Inc.—and not because of the 2010 health reform law.
Executives at Roche Diagnostics expect the wave of austerity measures being taken by western governments—including the United States—to as much as double its sales of fluid- and DNA-based tests in the next three years.
